abstract |
An anti-PD-L1/anti-4-1 BB bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between 4-1 BB and its ligand is provided. The bispecific antibody may have high binding affinity to both of a PD-L1 protein and a 4-1 BB protein. |